SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-143404
Filing Date
2020-05-15
Accepted
2020-05-15 08:00:35
Documents
3
Period of Report
2020-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812812d8k.htm 8-K 17827
2 EX-99.1 d812812dex991.htm EX-99.1 7945
3 GRAPHIC g812812g0515072242098.jpg GRAPHIC 3195
  Complete submission text file 0001193125-20-143404.txt   31459
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39112 | Film No.: 20880653
SIC: 2836 Biological Products, (No Diagnostic Substances)